Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.91 USD | -2.48% | +1.20% | -4.52% |
Financials (USD)
Sales 2024 * | 126M | Sales 2025 * | 145M | Capitalization | 181M |
---|---|---|---|---|---|
Net income 2024 * | 6M | Net income 2025 * | 18M | EV / Sales 2024 * | 1.43 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.24 x |
P/E ratio 2024 * |
26.9
x | P/E ratio 2025 * |
10.2
x | Employees | 459 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.63% |
Latest transcript on Lifecore Biomedical, Inc.
1 day | -2.48% | ||
1 week | +1.20% | ||
Current month | +1.20% | ||
1 month | -10.05% | ||
3 months | -25.47% | ||
6 months | -5.74% | ||
Current year | -4.52% |
Managers | Title | Age | Since |
---|---|---|---|
John Morberg
DFI | Director of Finance/CFO | 60 | 21-01-17 |
Steve Laninga
COO | Chief Operating Officer | - | 19-12-31 |
Matt Augustson
CTO | Chief Tech/Sci/R&D Officer | - | 22-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nelson Obus
BRD | Director/Board Member | 77 | 18-10-11 |
Jeffrey Edwards
BRD | Director/Board Member | 63 | 20-10-13 |
Katrina Houde
BRD | Director/Board Member | 66 | 19-08-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +9.52% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 5.91 | -2.48% | 124,661 |
24-06-06 | 6.06 | +3.41% | 235,221 |
24-06-05 | 5.86 | +6.35% | 208,326 |
24-06-04 | 5.51 | -5.16% | 152,414 |
24-06-03 | 5.81 | -0.51% | 147,784 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.52% | 181M | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.77% | 248B | |
-1.96% | 219B | |
+10.85% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- LFCR Stock